Fierce Pharma Biopharma News & Insights
WEB3 days ago · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Big Pharma Companies Ranked by Revenue 2022 | Fierce Pharma
WEBApr 18, 2023 · Small revenue declines were registered by Novartis (2%), Bristol Myers Squibb (0.5%) and Gilead Sciences (0.1%). Falling out of the top 20 from last year is Viatris, which saw a 9% revenue decline ...
The top 10 generic drug makers by 2021 revenue - Fierce Pharma
WEBAfter a period of stagnant sales largely because of increased competition and pricing pressures, the generic drug industry took another hit during the coronavirus pandemic. In its 10-K annual ...
The top 10 most profitable pharma companies in 2021
WEBThe six largest drugmakers by 2021 revenue—J&J, Pfizer, Roche, AbbVie, Novartis and Merck & Co.—all made the top profit list but in quite a different order.
The top 10 antibody-drug conjugate contenders in 2021
WEBOther add-on partners that it’s testing include AbbVie-shared Venclexta, and CD20xCD3 bispecific antibodies mosunetuzumab and glofitamab. Welford’s 2021 sales projection for Roche’s two ADCs ...
He's in! 'Shark Tank' star Cuban launches generics maker …
WEBJan 14, 2021 · Cuban is now bringing that vision for low-cost drugs to life, but he’s far from alone in his mission. In 2018, five U.S. health systems representing more than 450 hospitals launched a nonprofit ...
The top 10 best-paying places to work in biopharma
WEBPaying well is one way to lure job seekers in and keep existing talent happy, in biopharma and beyond. And while CEOs often catch the limelight for their multimillion-dollar paychecks, it is every ...
Sinopharm chief says COVID-19 vaccine will cost less than $145 …
WEBAug 18, 2020 · Sinopharm chief says COVID-19 vaccine will cost less than $145 for 2-dose regimen. The head of China’s state-owned Sinopharm has put forward a general price range for the group’s two ...
After delays, Pfizer's blockbuster-to-be eczema drug Cibinqo …
WEBJan 14, 2022 · After a series of delays and a lengthy safety review, Pfizer is on the scene in atopic dermatitis with a blockbuster-to-be. Friday, the FDA approved the New York drugmaker's oral daily JAK1 ...
FDA asks for 55 years to complete FOIA request on Pfizer's COVID …
WEBNov 19, 2021 · According to the documents filed (PDF) in a U.S. District Court for the Northern District of Texas, the FDA asked a federal judge for 55 years to complete a FOIA request for data and information ...
Skip to content